Latest Breaking News On - Severity index - Page 5 : comparemela.com

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis

Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index 75 in the POETYK PSO long-term.

United statesAlyssa johnsenApril armstrongLos angelesBristol myers squibbLaboratory abnormalitiesUniversity of californiaProgram toEuropean academy of dermatologyClinical trial programExchange commissionAmgen incBristol myers squibb company adverse eventPsoriasis areaSeverity indexGlobal assessment

Bristol Myers: positive results in psoriasis

Bristol Myers Squibb today announced new four-year results from the extension of a trial of Sotyktu in adult patients with moderate-to-severe plaque psoriasis. The data [.] continue to reinforce.

Alyssa johnsenBristol myers squibbBristol myersPsoriasis areaSeverity indexStatic physician global assessment

New 4-Year Extension Trial Results Announced for Deucravacitinib Treatment of Psoriasis

New 4-Year Extension Trial Results Announced for Deucravacitinib Treatment of Psoriasis
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United statesApril armstrongLos angelesBristol myers squibbEuropean academy of dermatologyHealth aprilw armstrongUniversity of californiaPsoriasis areaSeverity indexGlobal assessmentMyers squibb

Risankizumab Effective for Psoriasis Over 18 Months in Real World Settings

Risankizumab Effective for Psoriasis Over 18 Months in Real World Settings
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Czech republicFrankfurt am mainAndreas pinterUniversity hospital frankfurt am main departmentInternational psoriasis council andreas pinterInternational medical chart reviewInternational psoriasis councilUniversity hospital frankfurtInvestigator global assessmentGlobal assessmentPsoriasis areaSeverity indexDermatology life quality indexWorld long term effectivenessRisankizumab among patientsModerate to severe psoriasis

BoNT-A Injection Shows Prolonged Efficacy in Patients With Nail Psoriasis, Study Finds

BoNT-A Injection Shows Prolonged Efficacy in Patients With Nail Psoriasis, Study Finds
ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.

United statesJournal of the american academy dermatologyImage creditAmerican academyNail psoriasis severity indexPsoriasis areaSeverity index